Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension

Background: The aim of this study was to examine the action of inhaled nitric oxide in the patients with pulmonary hypertension administered with a face mask before anesthesia induction. Methods: Ten adult patients scheduled for heart surgery with sternotomy were included in this prospective, interventional, single centre study. The inclusion criteria were patients scheduled for heart surgery with sternotomy with cardiopulmonary bypass (CPB), aged >18 years which presents a pulmonary hypertension (PH) (class 2 or 3 according to the Dana Point classification) with systolic pulmonary arterial pressure (PAPS) >40 mmHg diagnosed by preoperative right cardiac catheterization or by transthoracic echocardiography. The exclusion criteria were: heart transplant, PH of type 1, 4, 5, according to the Dana Point classification, methemoglobin reductase deficit, incapacity to understand the protocol and sign the consent. Results: The administration of iNO decrease pulmonary hypertension (P < 0,001 compared to room air; P = 0,01 compared to pure oxygen administration). The iNO administration did not improve arterial blood oxygenation. The hyperoxia, decrease the cardiac index even with right ventricular post charge decrease. The increased blood oxygenation content cause systemic vascular vasoconstriction and decrease the peripheral oxygen extraction showed with VO2 linear increase (P < 0,001). Conclusions: The administration of inhaled nitric oxide with a face mask before anaesthesia induction is safe and effective method to reduce pulmonary hypertension. The oxygen and hyperoxia influences the systemic vascular resistance and peripheral oxygen consumption.

[1]  G. Finco,et al.  Nitric Oxide in Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. , 2018, Journal of cardiothoracic and vascular anesthesia.

[2]  M. Sarkar,et al.  Pulmonary Hypertension and Cardiac Anesthesia: Anesthesiologist's Perspective , 2018, Annals of cardiac anaesthesia.

[3]  A. Cheung,et al.  Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations? , 2017, Journal of cardiothoracic and vascular anesthesia.

[4]  B. Merkely,et al.  Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[5]  P. Bhatraju,et al.  Inhaled nitric oxide: Current clinical concepts. , 2015, Nitric oxide : biology and chemistry.

[6]  A. S. Spoelstra-de Man,et al.  Cardiovascular effects of hyperoxia during and after cardiac surgery , 2015, Anaesthesia.

[7]  A. Simon,et al.  Inhaled nitric oxide in cardiac surgery: Evidence or tradition? , 2015, Nitric oxide : biology and chemistry.

[8]  Nicholas R. Teman,et al.  Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia. , 2015, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[9]  L. Stansbury,et al.  Pulmonary hypertension in patients undergoing cardiac surgery: pathophysiology, perioperative management, and outcomes. , 2013, Journal of cardiothoracic and vascular anesthesia.

[10]  H. Seyfarth,et al.  Perioperative Anesthesiological Management of Patients with Pulmonary Hypertension , 2012, Anesthesiology research and practice.

[11]  P. Heerdt,et al.  Anesthesia and pulmonary hypertension. , 2012, Progress in cardiovascular diseases.

[12]  H. Poor,et al.  Pulmonary hypertension in the intensive care unit. , 2012, Progress in cardiovascular diseases.

[13]  O. Habler,et al.  Hyperoxia Reversibly Alters Oxygen Consumption and Metabolism , 2012, TheScientificWorldJournal.

[14]  D. Matamis,et al.  Inhaled NO and Sildenafil Combination in Cardiac Surgery Patients With Out-of-Proportion Pulmonary Hypertension: Acute Effects on Postoperative Gas Exchange and Hemodynamics , 2012, Circulation. Heart failure.

[15]  E. Jacobsohn,et al.  Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management. , 2011, Journal of cardiothoracic and vascular anesthesia.

[16]  E. Walker,et al.  Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. , 2011, Respiratory medicine.

[17]  R. Pearl,et al.  Anesthesia for patients with pulmonary hypertension , 2010, Current opinion in anaesthesiology.

[18]  A. Denault,et al.  Pulmonary Hypertension in Cardiac Surgery , 2009, Current cardiology reviews.

[19]  Stefan Fischer,et al.  Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. , 2008, Journal of cardiothoracic and vascular anesthesia.

[20]  F. Fedele,et al.  Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study , 2006, Journal of cardiovascular medicine.

[21]  C. Dani,et al.  Inhaled nitric oxide. , 2005, The New England journal of medicine.

[22]  J. Lehot,et al.  [Inhaled nitric oxide: therapeutic applications in cardiac surgery]. , 2000, Bulletin de l'Academie nationale de medecine.